Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 10, 1999

View Archived Issues

Increasingly Global Market Helps Bridge Atlantic Divide

UK, Italian Researchers Seek Role Of Infection In Leukemia

PPL Reduces Staff By 80 As Program Delays Force Cuts

Genset, Energy Commission Align In Genotyping Project

Evax Completes DM16M Round For 'Bacterial Ghost' Vaccines

Other News To Note

Devgen Enters Collaboration In Pesticides With FMC Unit

Wilex Implements Plan For Trials Of Cancer Antibody

Europe, U.S. Close WTO Gap On Issues Related To Biotech

Peptech Gains On News That TNF Patent Upheld In Europe

XTL Gets Footing In U.S. Through New Subsidiary

Pharming Plans Extension Of Phase II In Pompe's Disease

Biotrin's TAP Product Performs Well In Acute Pancreatitis Study

Ontario Creates C$20M Fund To Boost Biotech In Province

Qiagen, Affymetrix Agree To Develop Nucleic Acid Solutions

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...